David S. Kabakoff, Ph.D.

David S. Kabakoff, Ph.D.
Executive Partner
Sofinnova Ventures

Dr. Kabakoff has served as a member of the Board since November 2005. Dr. Kabakoff has served as Executive Partner of Sofinnova Ventures from May 2007 to the present. He has also served as President and Chief Executive Officer of Strategy Advisors, LLC, a consulting company, from August 2000 to the present. From January 2001 to June 2005, when it was acquired by Cephalon, Inc., a biotechnology company, Dr. Kabakoff served as the founder, Chairman and Chief Executive Officer of Salmedix, Inc., a biotechnology company. From May 1996 to August 2000, Dr. Kabakoff served in senior executive positions at Dura Pharmaceuticals Inc., a specialty pharmaceuticals company that was acquired by Elan Pharmaceuticals. Dr. Kabakoff currently serves as Chairman of the board of directors of Trius Therapeutics. He also serves on the boards of directors of several private companies. Dr. Kabakoff holds a B.A. in Chemistry from Case Western Reserve University and a Ph.D. in Chemistry from Yale University.